The Conundrum of Exercise for Weight Management in the GLP-1 Receptor Agonist Era

JAMA 2026

View at publisher
Authors: Daniel E. Lieberman, Daniel H. Aslan, Steven B. Heymsfield
DOI: 10.1001/jama.2026.5537
Cited by: 3
References: 23

Abstract

This Perspective describes the challenges of prescribing exercise for weight loss, with and without the use of glucagon-like peptide 1 (GLP-1) receptor agonists, and discusses strategies clinicians can use to improve adherence to exercise recommendations.

Fields of Study & Subjects

Diabetes Treatment and Management Pharmacology and Obesity Treatment Adipose Tissue and Metabolism

Publication details

Journal / source
JAMA
Publisher
American Medical Association (AMA)
Volume
335
Issue
21
Pages
1841–1841
Publication date
4 May 2026
Language
EN